We are live on
!
Find out more
WCBA
Weaver C. Barksdale & Associates Portfolio holdings
AUM
$105M
1-Year Est. Return
13.81%
This Fund
S&P 500
This Quarter
Est. Return
+3.92%
1 Year Est. Return
+13.81%
3 Year Est. Return
+40.08%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$62M
AUM Growth
+$2.53M
(+4.2%)
Cap. Flow
+$601K
Cap. Flow
% of AUM
0.97%
Top 10 Holdings %
Top 10 Hldgs %
17.86%
Holding
562
New
23
Increased
266
Reduced
152
Closed
30
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Principal Financial Group
PFG
|
+$1.05M |
| 2 |
CVS Health
CVS
|
+$1.04M |
| 3 |
Medtronic
MDT
|
+$916K |
| 4 |
United Parcel Service
UPS
|
+$322K |
| 5 |
Novartis
NVS
|
+$316K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coca-Cola
KO
|
+$881K |
| 2 |
GE Aerospace
GE
|
+$831K |
| 3 |
Eli Lilly
LLY
|
+$639K |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$373K |
| 5 |
Kohl's
KSS
|
+$239K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.59% |
| 2 | Industrials | 14.22% |
| 3 | Healthcare | 13.42% |
| 4 | Financials | 12.85% |
| 5 | Consumer Discretionary | 12.43% |
Similar funds
EW
AFG
ANBOT
P
SPW
SHF
NS
ACA
Weaver C. Barksdale & Associates's Q4 2016 Portfolio in Review
As of Q4 2016, Weaver C. Barksdale & Associates held 562 positions worth $62M, up 4.2% from $59.5M the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Weaver C. Barksdale & Associates's Q4 2016 filing shows 23 new, 266 increased, 152 reduced and 30 closed positions. Its largest new stake was Principal Financial Group: 18,823 shares worth $1.09M. The largest sale was Coca-Cola, an estimated $881K.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Industrials and Healthcare.
- Weaver C. Barksdale & Associates's largest Q4 2016 buy was Principal Financial Group: 18,823 shares worth $1.09M.
- Weaver C. Barksdale & Associates added most to United Parcel Service in Q4 2016, an estimated $322K increase.
- Weaver C. Barksdale & Associates's biggest Q4 2016 reduction was Eli Lilly, cutting an estimated $639K.
- Weaver C. Barksdale & Associates fully exited Coca-Cola in Q4 2016, selling an estimated $881K.
- Weaver C. Barksdale & Associates's ten largest holdings make up 18% of its $62M portfolio in Q4 2016.
- Weaver C. Barksdale & Associates opened 23 new positions and closed 30 in Q4 2016.
- Weaver C. Barksdale & Associates's portfolio value rose 4.2% quarter-over-quarter to $62M.
Based on Weaver C. Barksdale & Associates's 13F filing for Q4 2016, filed 26 Jan 2017.